Current Practices in Sickle Cell Disease - Image 1

£114.00

IntechOpen Current Practices in Sickle Cell Disease

Name: Current Practices in Sickle Cell Disease
Brand: IntechOpen
Price: 114.0 GBP
Availability: InStock

Medical Sciences A-Z

It has never been this cheap. We have no record of a lower price.

£114 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 82 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £119 (56 days, 68.3%)

Price range: £114 - £119

Price levels: 2 different prices over 82 days

Description

Sickle cell anemia is an inherited disorder of the globin chains that causes hemolysis and chronic organ damage. Sickle cell anemia is the most common form of sickle cell disease (SCD), with a lifelong affliction of hemolytic anemia requiring blood transfusions, pain crises, and organ damage. Since the first description of the irregular sickle-shaped red blood cells (RBCs) more than 100 years ago, our understanding of the disease has evolved tremendously. Recent advances in the field, more so within the last three decades, have alleviated symptoms for countless patients, especially in high-income countries. Although there is evidence of several important therapies in the pipeline, greater investment in research is needed into both of these therapies and the dissemination of effective care to the affected population, especially because of historical mistrust. In this book, we present an overview of sickle cell disease, pathogenesis, clinical presentation, complications, and recent treatment modalities and prospective research that will enable the reader to get a better understanding of this hot topic.

Product Specifications

Brand: IntechOpen
Format: hardcover
ASIN: 0854669205
Category: Books > Subjects > Science, Nature & Maths > Medicine > Medical Sciences A-Z
Domain: Amazon UK
Release Date: 11 September 2024
Listed Since: 21 September 2024

Barcode

No barcode data available

IntechOpen Current Practices in Sickle Cell Disease

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Sickle Cell Syndromes, An Issue of Hematology/Oncology Clinics of North America: Volume 36-6 (The Clinics: Internal Medicine, Volume 36-6)

Inherited Blood Disorders - Advances in Diagnosis and Treatment

Blood: Updates on Hemodynamics and on Thalassemia

Inherited Hemoglobin Disorders

Current Topics in Anemia

The 2025-2030 World Outlook for Sickle Cell Anemia Treatments

IntechOpen Hematology: Science and Practice - Medical Book

Recent Developments in Myelodysplastic Syndromes

Myelodysplastic Syndromes

Hematology - Latest Research and Clinical Advances

Young ∗aplastic∗ Anemia – Stem Cell Biology And Advances In Treatment

Current Developments in Hematology

New Frontiers in Hematology

IntechOpen Anemia - Medical Health and Internal Medicine Book

Current Research in Hematology

T-Cell Leukemia

Hematology: Research and Practice

Current Progress in Hematology

Beta Thalassemia

Hematology in Practice

Hematology: Clinical Aspects and Applications

Decision Making Through Problem Based Learning in Hematology: A Step-by-Step Approach in patients with Anemia

Nonmalignant Hematology: Expert Clinical Review: Questions and Answers

Myeloid Leukemia